56 medicines held by Sanofi-Aventis Deutschland GmbH on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Lantus 100 units/ml solution for injection in a vial EU/1/00/134/001 |
Insulin glargine | Sanofi-Aventis Deutschland GmbH | — |
| Lantus 100 units/ml solution for injection in a vial EU/1/00/134/002 |
Insulin glargine | Sanofi-Aventis Deutschland GmbH | — |
| Lantus 100 units/ml solution for injection in a vial EU/1/00/134/003 |
Insulin glargine | Sanofi-Aventis Deutschland GmbH | — |
| Lantus 100 units/ml solution for injection in a vial EU/1/00/134/004 |
Insulin glargine | Sanofi-Aventis Deutschland GmbH | — |
| Lantus SoloStar 100 units/ml solution for injection in a pre-filled pen EU/1/00/134/030-037 |
Insulin glargine | Sanofi-Aventis Deutschland GmbH | — |
| Toujeo (previously Optisulin) 300 units/ml SoloStar solution for injection in a pre-filled pen EU/1/00/133/033-035 |
Insulin glargine | Sanofi-Aventis Deutschland GmbH | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.